| Hengstermann, Theo (Optimare 201004 CEO) |
Chief Executive Officer (CEO) |
Aerodata (Group) |
Germany |
| Henig, Noreen Roth (201807– CMO before ProQR Therapeutics + Gilead Sciences) |
Chief Medical Officer (CMO) |
Zambon (Group) |
Germany |
| Heninger, Anne-Kristin (Seamless Therapeutics 202303 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Seamless Therapeutics GmbH |
Germany |
| Henke, Heinz-Werner (Innovative Tomography Products GmbH 201305 Managing Director) |
Managing Director |
Innovative Tomography Products GmbH (ITP Innotom) |
Germany |
| Henkel, Thomas (IMD Natural Solutions 201508 Managing Director + Co-Founder + Imax Discovery before Bayer) |
Managing Director |
IMD Natural Solutions (INS) (Group) |
Germany |
| Henkel, Thomas (Targos Molecular Pathology GmbH 201201 Managing Director) |
Managing Director |
Targos Molecular Pathology GmbH |
Germany |
| Henn, Hans-Joachim (Bayer 201606 Global Head of Anti-Counterfeit Management) |
n. a. |
Bayer (Group) |
Germany |
| Hennecke, Anne (MC Services 201211 Managing Partner before Evotec + Schwarz Pharma) |
public relations / investor relations |
MC Services AG |
Germany |
| Hennecke, Jens (PPF Group 201503– CBO at Sotio as before Micromet VP BusDev) |
Chief Business Officer (CBO) |
PPF Group (Group) |
Czech Republic |
| Hennemann, Hanjo (VeroVaccines GmbH 201707– Managing Direcotor + Co-Founder before Nexigen GmbH) |
Managing Director |
VeroVaccines GmbH |
Germany |
| Hennig, Christian (Zellkraftwerk 201301) |
Company Founder |
Bruker (Group) |
Germany |
| Henrichsen, Frank (Nanion Technologies 201601– Director of Global Sales before Sophion Bioscience) |
Sales Manager / Marketing Manager |
Nanion (Group) |
Germany |
| Hensel, Frank (High-Tech Gründerfonds 201603) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Hentsch, Bernd (4SC 201009–201403 Chief Development Officer LEFT 3/14) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Germany |
| Hentschel, Norbert (Miltenyi Biotec 201308 Managing Director) |
Managing Director |
Miltenyi Biotec (Group) |
Germany |
| Hentz, Marc W. (AMP Biosimilars AG 201505 CEO before AMP-Therapeutics GmbH 201210 Managing Director) |
Chief Executive Officer (CEO) |
AMP Biosimilars AG |
Germany |
| Hentze, Matthias W. (EMBL 201702 Director) |
President/Director/Head of Research Organisation/Unit |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Henze, Kirstin (Danaher 201104 Director Communications + Corporate Identity at Leica Microsystems) |
Public Relations Manager / Investor Relations Manager |
Danaher (Group) |
Germany |
| Hepberger, Rainer (Innovacell 201204– CFO) |
Chief Financial Officer (CFO) |
Innovacell (Group) |
Austria |
| Hepburne-Scott, Charlotte (Optimum Strategic Communications 202104) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Herbeaux, Jean-Luc (Hovione 202204– CEO joined 5/20 as COO before Evonik Head of Health Care business) |
Chief Executive Officer (CEO) |
Hovione (Group) |
Portugal |
| Herberg, Axel (Gerresheimer 200703 President + CEO) |
Chief Executive Officer (CEO) |
Gerresheimer (Group) |
Germany |
| Herbers, Karin (SunGene GmbH 200502 Managing Director) |
Managing Director |
BASF (Group) |
Germany |
| Herbert, Susan Jane (Merck (DE) 201109 Head Global Portfolio Development at Merck Serono) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
| Hergenhan, Sophia (Trophic Communications 202106) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Herklots, Hans (LifeSci 201805 LifeSci Advisors before Carpicorn One + TiGenix) |
Public Relations Manager / Investor Relations Manager |
LifeSci (Group) |
United States (USA) |
| Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel) |
Chief Financial Officer (CFO) |
Bruker (Group) |
United States (USA) |
| Hermance, Frank S. (Ametek 201408 CEO) |
Chief Executive Officer (CEO) |
AMETEK (Group) |
United States (USA) |
| Hermann, Frank (4SC 201610– promoted CDO joined recently from BMS) |
Research & Development Manager |
4SC (Group) |
Germany |
| Hermann, Ralf (Eppendorf –201610 Chief Marketing + Portfolio Manager LEFT 10/16 before Sartorius/Vivascience + Qiagen) |
Board member, executive |
Eppendorf (Group) |
Germany |
| Hermansen, Ronny (Genetic Analysis 202110 CEO formerly Axis-Shield) |
Chief Executive Officer (CEO) |
Genetic Analyis AS (GA) |
Norway |
| Hermatschweiler, Martin (Nanoscribe 2007– Managing Partner (CEO) + Co-Founder) |
Chief Executive Officer (CEO) |
Bico (Group) |
Germany |
| Hermes, Rene (Definiens AG 200611 Vice Pres Marketing) |
n. a. |
AstraZeneca (Group) |
Germany |
| Hernando Ariza, Ana (Bionomous 202208 COO + Co-Founder) |
Chief Operating Officer (COO) |
Bionomous S.A. |
Switzerland |
| Hernday, Natasha (Seattle Genetics 201306 VP Corporate Development) |
Business Development Manager / Strategy Manager |
Seagen (Group) |
United States (USA) |
| Herndon, Russell (Hydra Biosciences 201404 CEO) |
Chief Executive Officer (CEO) |
Hydra Biosciences Inc. |
United States (USA) |
| Herpel, Kurt (Delta 4 202006 CEO) |
Chief Executive Officer (CEO) |
Delta 4 GmbH (Delta4) |
Austria |
| Herr, Stefan (EMBL Ventures) |
Partner (venture partner) |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Herrema, Greg (Thermo Fisher 200703 President Scientific Instruments) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Herrendorff, Ruben (Polyneuron 201805 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Polyneuron Pharmaceuticals AG |
Switzerland |
| Herrenknecht, Kurt (SciArcum 201110– before Proteros + Zukunftsfonds Heilbronn + PerkinElmer + Evotec + Eisai) |
Business Development Manager / Strategy Manager |
SciArcum Biotech Consulting – Dr. Kurt Herrenknecht |
Germany |
| Herrgård, Markus (BioInnovation Institute 202206 CTO) |
Chief Technology/Technical Officer (CTO) |
BioInnovation Institute (BII Foundation) |
Denmark |
| Herrmann, Alexander (Gilupi GmbH 201605– Managing Director before Capsulution + Metabolomic Discoveries) |
General Manager (management) |
Viroad (Group) |
Germany |
| Herrmann, Andreas (Valerius Biopharma 201805 CEO + Founder before Alvotech + Celonic + Baliopharm + Synimmune + Cardion) |
Chief Executive Officer (CEO) |
Valerius Biopharma AG |
Switzerland |
| Herrmann, Brigitte (Rheinland-Pfalz (govt) 201601 Head of Venture Capital at ISB) |
Investment Manager |
Investitions- und Strukturbank Rheinland-Pfalz (ISB) |
Germany |
| Herrmann, Max (Silence Therapeutics 201108 CFO + acting CEO beforre Intercytex 200809– CFO) |
Chief Financial Officer (CFO) |
Silence Therapeutics (Group) |
United Kingdom (GB) |
| Herrmann, Reinhard (AVISO GmbH 200711 Managing Director) |
Managing Director |
Sartorius (Group) |
Germany |
| Herrmann, Rüdiger (Mayer Brown 200809 Frankfurt/M) |
n. a. |
Mayer Brown LLP |
Germany |
| Herron, Jennifer (ADC Therapeutics 201911–202212 CCO based in US before Immunogen + MorphoSys LEFT 12/22) |
Chief Commercial Officer (CCO) |
ADC Therapeutics (Group) |
United States (USA) |
| Herschel, Candice (LifeScience Connect 202309 Head of Community) |
n. a. |
LifeScience Connect Ltd. (LifeScience ORG) |
United Kingdom (GB) |
| Hertig, Christina (Galenica 201112 Head Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Galenica (Group) |
Switzerland |
| Hertzberg, Suzan (Ipsogen 200810 President of Ipsogen Inc + VP Corporate BusDev) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
United States (USA) |
| Herzberg, Dennis (Cluster Industrielle Biotechnologie 202307 Cluster Manager) |
Cluster Manager |
Cluster Industrielle Biotechnologie e. V. (CLIB –Cluster for Industrial Biotechnolog) |
Germany |
| Herzog, Christian (Holtzbrinck 202306 Chief Product Officer at Digital Science + Co-Founder of Dimensions) |
Product Manager (personnel) |
Holtzbrinck (Group) |
United Kingdom (GB) |
| Herzog, Ruth |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Hess, Heribert (Tecan 2012– Manager Commercial Operations D-A-CH) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Germany |
| Hess, Matthias (AnalytiCon Discovery 200504) |
n. a. |
BRAIN Biotech (Group) |
Germany |
| Hess, René (Eppendorf 202209 Managing Director of DASGIP) |
Managing Director |
Eppendorf (Group) |
Germany |
| Hessing, Michael |
n. a. |
Dr. Schmidt (Group) |
Germany |
| Hesslein, Robert (Bob) (Voyager Therapeutics 201901– General Counsel before Foundation Medicine + Genzyme) |
General Counsel / Chief Legal Officer (CLO) |
Voyager Therapeutics Inc. (Nasdaq: VYGR) |
United States (USA) |
| Hetke, Christian (Futalis GmbH 201111– Managing Director + Co-founder) |
Managing Director |
Futalis GmbH |
Germany |
| Hettich, Andreas (Hettich Beteiligungen) |
n. a. |
Dr. Hettich Beiligungen GmbH (Andreas Hettich) |
Germany |
| Hettich, Christof (Kanzlei Rittershaus + Dievini Hopp) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
| Heuer, Anja (Immatics 201907 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Immatics (Group) |
Germany |
| Heuer, Michael (Roche 201810– interim CEO of Roche Diagnostics before Region Head EMEA + Latin America joined BM 1983) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Heukamp, Wessel (Freshfields Bruckhaus Deringer 201610) |
Attorney / Lawyer |
Freshfields (Group) |
United Kingdom (GB) |
| Heumann, Hermann (Silantes GmbH 201902 Managing Director) |
Managing Director |
Silantes GmbH |
|
| Heumann, Klaus (Biomax 200611 CEO) |
Chief Executive Officer (CEO) |
Biomax (Group) |
Germany |
| Heumann, Klaus (Univ Mainz 200701 Professor for Inorganic and Analytical Chemistry) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
| Heydler, Thomas P. (Definiens 200411– CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
Germany |
| Heyne, Wilfried (Humedics GmbH 201110 Managing Director) |
Managing Director |
Humedics GmbH |
Germany |
| Heyse, Stephan (Genedata 200701 Head of Genedata Screener) |
Product Manager (personnel) |
Genedata (Group) |
Switzerland |
| Heß, Markus (Astra Diagnostics 201105 Managing Director) |
Managing Director |
ADT Altona Diagnostic Technologies GmbH (Altona Diagnostics) |
Germany |
| Heß, Rüdiger (PXBioVision 201104 Managing Director) |
Managing Director |
PXBioVisioN GmbH |
Germany |
| Heßler, Nadine (JeNaCell GmbH 201210 Managing Director) |
Managing Director |
JeNaCell GmbH |
Germany |
| Hibbs, Kathy L. (23andMe 202101 Chief Legal + Regulatory Officer before Genomic Health + Monogram Biosciences) |
General Counsel / Chief Legal Officer (CLO) |
23andMe Inc. |
United States (USA) |
| Hickey, Dave (Siemens 200805 SVP Strategic Planning + BusDev at Siemens Healthcare Diagnostics) |
Business Development Manager / Strategy Manager |
Siemens (Group) |
Germany |
| Hicks, Dave (Danaher 201004 VP + General Manager Pharmaceuticals + Proteomics at AB SCIEX) |
General Manager (management) |
Danaher (Group) |
Canada |
| Higashi, Shunichi (Miraca 201808 CEO of Srl Inc) |
Chief Executive Officer (CEO) |
Miraca (Group) |
Japan |
| Higgins, Arthur J. (Bayer HealthCare CEO 200407–201004 LEFT 4/10) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Higgins, John L. (Ligand –200710– President + CEO) |
Chief Executive Officer (CEO) |
Ligand (Group) |
United States (USA) |
| Higham, Paul G. (Valo Therapeutics 202008– CEO before Glycotope + Immatics + Ark Therapeutics + GlaxoWellcome) |
Chief Executive Officer (CEO) |
Valo Therapeutics (Valo Tx) (Group) |
Finland |
| Hilbert, Helmut (Curetis 201303– Head Business Development before Qiagen Business Development) |
Business Development Manager / Strategy Manager |
OpGen (Group) |
Germany |
| Hilbrich, Lutz (Minapharm 202006– CEO of ProBioGen AG before Sanofi China + Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
Minapharm (Group) |
Germany |
| Hildemann, Steven (Merck (DE) 201401– Global CMO at Merck Serono before MSD/Merck US) |
Chief Medical Officer (CMO) |
Merck (DE) (Group) |
Germany |
| Hildinger, Markus (ExcellGene 200905 CBO) |
Chief Business Officer (CBO) |
ExcellGene S.A. |
Switzerland |
| Hilfrich, Ralf (Abviris 2014– Managing Director + Co-Founder) |
Managing Director |
Abviris Deutschland GmbH |
Germany |
| Hilgert, Lara (Gilde Investment, 202207– Investment Analyst at Gilde Healthcare in Ffm) |
Analyst (Financial / Industry) |
Gilde Investment (Group) |
Germany |
| Hilkert, Andreas (Thermo Fisher 201512 Senior Manager Product Marketing Inorganic Mass Spectrometry) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
| Hill, Adam M. (Oncimmune 201810– CEO joined 201803 before McLaren Applied Technologies) |
Chief Executive Officer (CEO) |
Freenome (Group) |
United Kingdom (GB) |
| Hill, Adrian (Univ Oxford 201506 Professor + Director of Jenner Institute) |
Professor |
University of Oxford |
United Kingdom (GB) |
| Hillebrand, Timo (Analytik Jena 201101 Managing Director AJ Innusreen GmbH) |
Managing Director |
IST Innuscreen GmbH |
Germany |
| Hillenkamp, Franz (Univ Münster Prof, co-inventor MALDI-TOF MS) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Hillgrove, Allan (Boehringer 201301– promoted Managing Director Div Marketing + Sales Prescription Medicines) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
| Hillisch, Alexander (Bayer HealthCare AG 200508) |
n. a. |
Bayer (Group) |
Germany |
| Hils, Martin (Zedira 201106 CEO + co-founder before N-Zyme Biotec) |
Managing Director |
Zedira GmbH |
Germany |
| Hilterhaus, Dierk (Xtal Concepts 201208 Managing Director) |
Managing Director |
Xtal Concepts GmbH |
Germany |
| Hilvert, Donald (ETH Zürich 201310 Professor at Lab for Organic Chemistry) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Himmler, Gottfried (f-star 200709 CEO + co-founder) |
Chief Executive Officer (CEO) |
Sino Biopharm (Group) |
Austria |
| Hing, Paul (Sensovation 201110 CTO) |
Chief Technology/Technical Officer (CTO) |
Miltenyi Biotec (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 30 31 32 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
